Worldwide Study Finder

Not applicableCompletedINTERVENTIONAL

Post-Operative Water Load Following Transsphenoidal Pituitary Surgery

ClinicalTrials.gov · NCT02727686 · Registry updated: 2019-11-25

Condition / research focus: Hyponatremia; Pituitary Adenoma
Sponsor: St. Joseph's Hospital and Medical Center, Phoenix
Countries with listed sites: United States
Registry dates and results: Start: 2016-03-07. Completion: 2018-12-13 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Water Load (WL) Post-Operative Day 1 (other)

Where the study takes place — 1 listed sites

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

Barrow Brain and Spine
Phoenix, Arizona, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

High-Volume Plasma Exchange Versus Standard Medical Treatment in Patients With Acute Liver Failure

ClinicalTrials.gov · NCT02718079 · Registry updated: 2019-11-20

Condition / research focus: Acute Liver Failure
Sponsor: Institute of Liver and Biliary Sciences, India
Countries with listed sites: India
Registry dates and results: Start: 2016-12-30. Completion: 2018-10-18 (may be estimated). No results posted in this registry response.

Products and interventions (11)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Plasma Exchange (biological)
Management of cerebral edema/intracranial hypertension: (other)
Transfer to Intensive Care Unit (other)
Prophylactic Antibiotics (drug)
Intubation of trachea (other)
Administration of mannitol or 3% saline for severe elevation of Intra Cranial Pressure (other)
Volume Replacement (other)
Pressor Support (other)
N-acetyl-L-cysteine (drug)
Correction of metabolic parameters (other)
Correction of nutrition (dietary_supplement)

Where the study takes place — 1 listed sites

Institute of liver and Biliary Sciences
New Delhi, National Capital Territory of Delhi, India
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2CompletedINTERVENTIONAL

Study of the Effect of Intradialytic Vasopressin on Chronic Hypertension in Patients With End Stage Renal Disease

ClinicalTrials.gov · NCT01247090 · Registry updated: 2019-11-18

Condition / research focus: Hypertension; End Stage Renal Disease
Sponsor: Columbia University
Countries with listed sites: United States
Registry dates and results: Start: 2010-10. Completion: 2018-08 (may be estimated). Results are posted in this registry.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Vasopressin - Very Low Dose (drug) — also listed as: Vasopressin Injection, USP (8-L arginine vasopressin), AVP, Pitressin®
Vasopressin - Low Dose (drug) — also listed as: Vasopressin Injection, USP (8-L arginine vasopressin), AVP, Pitressin®
Placebo Comparator (drug) — also listed as: Normal saline

Where the study takes place — 1 listed sites

Columbia University Medical Center
New York, New York, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

Comparison of Oral or Intravenous Thiazides vs Tolvaptan in Diuretic Resistant Decompensated Heart Failure

ClinicalTrials.gov · NCT02606253 · Registry updated: 2019-11-08

Condition / research focus: Heart Failure
Sponsor: Vanderbilt University
Countries with listed sites: United States
Registry dates and results: Start: 2016-02. Completion: 2018-10-31 (may be estimated). Results are posted in this registry.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

tolvaptan (drug) — also listed as: Samsca
Chlorothiazide (drug) — also listed as: Diuril
Metolazone (drug) — also listed as: Zaroxolyn

Where the study takes place — 1 listed sites

Vanderbilt University Medical Center
Nashville, Tennessee, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2WithdrawnINTERVENTIONAL

Intranasal Oxytocin and Learning in Autism

ClinicalTrials.gov · NCT02090829 · Registry updated: 2019-11-01

Condition / research focus: Autism Spectrum Disorders
Sponsor: University of Minnesota
Countries with listed sites: United States
Registry dates and results: Start: 2014-03. Completion: 2018-03 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Syntocinon (synthetic oxytocin) (drug) — also listed as: Syntocinon
Placebo (other)

Where the study takes place — 1 listed sites

Center for Neurobehavioral Development
Minneapolis, Minnesota, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

Tolvaptan Versus Fluid Restriction in SIADH

ClinicalTrials.gov · NCT04119206 · Registry updated: 2019-10-08

Condition / research focus: Hyponatremia; Syndrome of Inappropriate ADH (SIADH) Secretion; Pituitary
Sponsor: University of Erlangen-Nürnberg Medical School
Countries with listed sites: No country reported
Registry dates and results: Start: 2009-01-01. Completion: 2013-12-31 (may be estimated). No results posted in this registry response.

Products and interventions (0)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Early Phase 1UnknownINTERVENTIONAL

Safety and Tolerability Analysis of Combining Desmopressin With Docetaxel for the Treatment of Castration-Resistant Prostate Cancer

ClinicalTrials.gov · NCT04113005 · Registry updated: 2019-10-02

Condition / research focus: Castrate Resistance Prostate Cancer
Sponsor: Sunnybrook Health Sciences Centre
Countries with listed sites: No country reported
Registry dates and results: Start: 2019-10-01. Completion: 2020-10-01 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Desmopressin (drug)

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Phase 2UnknownINTERVENTIONAL

Methylene Blue Versus Vasopressin Analogue for Treatment of Septic Shock in Preterm Neonate

ClinicalTrials.gov · NCT04110418 · Registry updated: 2019-10-01

Condition / research focus: Neonatal Sepsis; Refractory Shock
Sponsor: Ain Shams University
Countries with listed sites: Egypt
Registry dates and results: Start: 2019-02-19. Completion: 2020-02-19 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Methylene Blue (drug) — also listed as: terlipressin acetate

Where the study takes place — 1 listed sites

Neonatal Intensive Care Units (NICUs), Ain Shams University
Cairo, Abbasia, Egypt
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 1CompletedINTERVENTIONAL

Trial of Vasopressin and Epinephrine to Epinephrine Only for In-Hospital Pediatric Cardiopulmonary Resuscitation

ClinicalTrials.gov · NCT00628550 · Registry updated: 2019-09-17

Condition / research focus: Cardiopulmonary Arrest; Cardiac Arrest
Sponsor: University of Texas Southwestern Medical Center
Countries with listed sites: United States
Registry dates and results: Start: 2008-04. Completion: 2010-10 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Vasopressin (drug) — also listed as: Pitressin
Epinephrine (drug) — also listed as: Adrenaline

Where the study takes place — 1 listed sites

Universtity of Texas Southwestern, Children's Medical Center
Dallas, Texas, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

Trial of Desmopressin Orally Disintegrating Tablets (ODT) for Nocturia Due to Nocturnal Polyuria in Japanese Female Subjects

ClinicalTrials.gov · NCT02905682 · Registry updated: 2019-09-11

Condition / research focus: Nocturia
Sponsor: Ferring Pharmaceuticals
Countries with listed sites: Japan
Registry dates and results: Start: 2016-09. Completion: 2017-09-27 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Desmopressin (drug) — also listed as: FE 992026
Placebo (drug)

Where the study takes place — 1 listed sites

Investigational site (there may be other sites in this country)
Tokyo, Japan
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

Trial of Desmopressin Orally Disintegrating Tablets (ODT) for Nocturia Due to Nocturnal Polyuria in Japanese Male Subjects

ClinicalTrials.gov · NCT02904759 · Registry updated: 2019-09-11

Condition / research focus: Nocturia
Sponsor: Ferring Pharmaceuticals
Countries with listed sites: Japan
Registry dates and results: Start: 2016-09. Completion: 2017-09-29 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Desmopressin (drug) — also listed as: FE 992026
Placebo (drug)

Where the study takes place — 1 listed sites

Investigational site (there may be other sites in this country)
Tokyo, Japan
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2CompletedINTERVENTIONAL

Hemodynamics and Extravascular Lung Water in Acute Lung Injury

ClinicalTrials.gov · NCT00624650 · Registry updated: 2019-09-10

Condition / research focus: Acute Lung Injury
Sponsor: Oregon Health and Science University
Countries with listed sites: United States
Registry dates and results: Start: 2008-02. Completion: 2011-01 (may be estimated). Results are posted in this registry.

Products and interventions (10)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Diuresis (furosemide) part I (drug)
Fluid Bolus (crystalloid or albumin) (other)
Fluid Bolus (crystalloid or albumin) (other)
Vasopressors (Norepinephrine, Vasopressin, Phenylephrine, Epinephrine) (drug)
Vasopressors (Norepinephrine, Vasopressin, Phenylephrine, Epinephrine) (drug)
Dobutamine (drug)
Dobutamine (drug)
Concentrate all drips and nutrition (other)
Diuresis (furosemide) part II (drug)
Dialysis (procedure)

Where the study takes place — 3 listed sites

Kaiser Permanente Sunnyside
Clackamas, Oregon, United States
Site recruitment: Not reported
Legacy Good Samaritan
Portland, Oregon, United States
Site recruitment: Not reported
Oregon Health and Science University
Portland, Oregon, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

To Assess Safety and Efficacy of Bolus Versus Continuous Infusion of Terlipressin in Acute Variceal Bleeding

ClinicalTrials.gov · NCT02695862 · Registry updated: 2019-09-04

Condition / research focus: Acute Variceal Bleeding
Sponsor: Institute of Liver and Biliary Sciences, India
Countries with listed sites: India
Registry dates and results: Start: 2016-05-05. Completion: 2018-01-31 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Terlipressin (drug)

Where the study takes place — 1 listed sites

Institute of liver and Biliary Sciences
New Delhi, National Capital Territory of Delhi, India
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableWithdrawnINTERVENTIONAL

The Effect of Water Intake on Glucose Regulation

ClinicalTrials.gov · NCT03765008 · Registry updated: 2019-08-28

Condition / research focus: Glucose Metabolism Disorders; Dehydration (Physiology); Water Deprivation
Sponsor: Arizona State University
Countries with listed sites: No country reported
Registry dates and results: Start: 2019-02-11. Completion: 2019-04-29 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Water intake manipulation (other)

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Phase 4UnknownINTERVENTIONAL

2- Day vs. 5- Day Terlipressin and Ceftriaxone in the Control Acute Gastroesophageal Variceal Hemorrhage

ClinicalTrials.gov · NCT04056806 · Registry updated: 2019-08-14

Condition / research focus: Variceal Rebleeding Rate and Infections
Sponsor: E-DA Hospital
Countries with listed sites: Taiwan
Registry dates and results: Start: 2019-08. Completion: 2022-08 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Terlipressin 1Mg Powder for Conventional Release Solution for Injection Vial (drug) — also listed as: Ceftriaxone 1gm

Where the study takes place — 1 listed sites

E-Da Hospital
Kaohsiung City, Taiwan
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Paracervical Versus Intracervical Lidocaine

ClinicalTrials.gov · NCT00816751 · Registry updated: 2019-08-13

Condition / research focus: Abortion, Induced; Pain
Sponsor: University of California, San Diego
Countries with listed sites: United States
Registry dates and results: Start: 2007-12. Completion: 2008-02 (may be estimated). Results are posted in this registry.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Paracervical block (procedure)
Intracervical (procedure)
Buffered Lidocaine, vasopressin, sodium bicarbonate (drug)

Where the study takes place — 1 listed sites

Planned Parenthood
San Diego, California, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

Laparoscopic Tubal Preservation Surgery

ClinicalTrials.gov · NCT03253588 · Registry updated: 2019-07-30

Condition / research focus: Ectopic Pregnancy
Sponsor: Far Eastern Memorial Hospital
Countries with listed sites: Taiwan
Registry dates and results: Start: 2017-02-21. Completion: 2017-10-15 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

laparoscopic salpingotomy or salpingostomy (procedure)

Where the study takes place — 1 listed sites

Far Eastern Memorial Hospital
Taipei, New Taipei City, Taiwan
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

Terlipressin on Effect of Renal Function in Cirrhotic Patients With Acute Gastrointestinal Hemorrhage

ClinicalTrials.gov · NCT03846180 · Registry updated: 2019-07-05

Condition / research focus: Variceal Hemorrhage; Cirrhosis, Liver; Kidney Injury
Sponsor: General Hospital of Shenyang Military Region
Countries with listed sites: China
Registry dates and results: Start: 2019-03-01. Completion: 2019-07-01 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Terlipressin (drug) — also listed as: Glypressin
Somatostatin (drug) — also listed as: Stilamin
Octreotide (drug) — also listed as: Sandostatin

Where the study takes place — 14 listed sites

Center for Liver Cirrhosis, The Fifth Medical Center of PLA General Hospital
Beijing, Beijing Municipality, China
Site recruitment: Not reported
Difficult & Complicated Liver Diseases and Artificial Liver Center, Beijing YouAn Hospital, Capital Medical University
Beijing, Beijing Municipality, China
Site recruitment: Not reported
Liver Research Center, The First Affiliated Hospital of Fujian Medical University
Fuzhou, Fujian, China
Site recruitment: Not reported
Department of Hepatobiliary Disease, 900 Hospital of the Joint Logistics Team (formerly called Fuzhou General Hospital)
Fuzhou, Fujian, China
Site recruitment: Not reported
Department of Gastroenterology, The First Affiliated Hospital of Nanchang University
Nanchang, Jiangxi, China
Site recruitment: Not reported
Department of Gastroenterology, The First Affiliated Hospital of China Medical University
Shenyang, Liaoning, China
Site recruitment: Not reported
Department of Critical Care Medicine, The Sixth People's Hospital of Shenyang
Shenyang, Liaoning, China
Site recruitment: Not reported
Department of Gastroenterology, Air Force Hospital of Northern Theater Command
Shenyang, Liaoning, China
Site recruitment: Not reported
Department of Gastroenterology, General Hospital of Northern Theater Command (formerly called General Hospital of Shenyang Military Area)
Shenyang, Liaoning, China
Site recruitment: Not reported
Department of Gastroenterology, Xi'an Central Hospital
Xi'an, Shaanxi, China
Site recruitment: Not reported
Department of Gastroenterology, Shandong Provincial Hospital Affiliated to Shandong University
Jinan, Shandong, China
Site recruitment: Not reported
Eastern Hepatobiliary Hospital of the Second Military Medical University
Shanghai, Shanghai Municipality, China
Site recruitment: Not reported
Department of Gastroenterology, General Hospital of Western Theater Command
Chengdu, Sichuan, China
Site recruitment: Not reported
State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, College of Medicine, Zhejiang University
Hangzhou, Zhejiang, China
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Early Phase 1TerminatedINTERVENTIONAL

Low Dose Vasopressin in Traumatic Shock

ClinicalTrials.gov · NCT00420407 · Registry updated: 2019-06-18

Condition / research focus: Injuries; Shock, Traumatic
Sponsor: The University of Texas Health Science Center at San Antonio
Countries with listed sites: United States
Registry dates and results: Start: 2007-02. Completion: 2011-02 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

normal saline control (drug)
vasopressin (drug)

Where the study takes place — 1 listed sites

University of Texas Health Science Center at San Antonio
San Antonio, Texas, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 1UnknownINTERVENTIONAL

Effects of SRX246 on an Experimental Model of Fear and Anxiety in Humans

ClinicalTrials.gov · NCT02922166 · Registry updated: 2019-06-10

Condition / research focus: Fear; Anxiety
Sponsor: Azevan Pharmaceuticals
Countries with listed sites: United States
Registry dates and results: Start: 2017-02-03. Completion: 2019-12 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

SRX246 (drug)
Placebo (drug)

Where the study takes place — 1 listed sites

National Institute of Mental Health
Bethesda, Maryland, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Worldwide Study Finder

Find a study

Registry search results

Post-Operative Water Load Following Transsphenoidal Pituitary Surgery

Explore the world’s study registries

Worldwide

Africa

Americas

High-Volume Plasma Exchange Versus Standard Medical Treatment in Patients With Acute Liver Failure

Study of the Effect of Intradialytic Vasopressin on Chronic Hypertension in Patients With End Stage Renal Disease

Comparison of Oral or Intravenous Thiazides vs Tolvaptan in Diuretic Resistant Decompensated Heart Failure

Intranasal Oxytocin and Learning in Autism

Tolvaptan Versus Fluid Restriction in SIADH

Safety and Tolerability Analysis of Combining Desmopressin With Docetaxel for the Treatment of Castration-Resistant Prostate Cancer

Methylene Blue Versus Vasopressin Analogue for Treatment of Septic Shock in Preterm Neonate

Trial of Vasopressin and Epinephrine to Epinephrine Only for In-Hospital Pediatric Cardiopulmonary Resuscitation

Trial of Desmopressin Orally Disintegrating Tablets (ODT) for Nocturia Due to Nocturnal Polyuria in Japanese Female Subjects

Trial of Desmopressin Orally Disintegrating Tablets (ODT) for Nocturia Due to Nocturnal Polyuria in Japanese Male Subjects

Hemodynamics and Extravascular Lung Water in Acute Lung Injury

To Assess Safety and Efficacy of Bolus Versus Continuous Infusion of Terlipressin in Acute Variceal Bleeding

The Effect of Water Intake on Glucose Regulation

2- Day vs. 5- Day Terlipressin and Ceftriaxone in the Control Acute Gastroesophageal Variceal Hemorrhage

Paracervical Versus Intracervical Lidocaine

Laparoscopic Tubal Preservation Surgery

Terlipressin on Effect of Renal Function in Cirrhotic Patients With Acute Gastrointestinal Hemorrhage

Low Dose Vasopressin in Traumatic Shock

Effects of SRX246 on an Experimental Model of Fear and Anxiety in Humans

Asia

Middle East

Europe

Oceania